Valeant Pharmaceuticals (VRX)
17.65
+0.11 +0.63%
NYSE
Apr 26, 09:06
Delayed 2m
USD
Valeant Pharmaceuticals Key Statistics
Stock Price Performance
1 Month Price Returns (Daily) | Upgrade |
3 Month Price Returns (Daily) | Upgrade |
6 Month Price Returns (Daily) | Upgrade |
Year to Date Price Returns (Daily) | Upgrade |
1 Year Price Returns (Daily) | 94.46% |
3 Year Price Returns (Daily) | Upgrade |
52 Week High (Daily) | Upgrade |
52 Week Low (Daily) | Upgrade |
52-Week High Date | Jan. 05, 2018 |
52-Week Low Date | Apr. 26, 2017 |
Dividends and Shares
Shares Outstanding | Upgrade |
Dividend | -- |
Dividend Yield (Forward) | Upgrade |
Dividend Yield (TTM) | Upgrade |
Cash Dividend Payout Ratio (TTM) | Upgrade |
Payout Ratio (TTM) | Upgrade |
Latest Dividend Pay Date | -- |
Next Ex-Dividend Date | -- |
Last Split Factor | 2.00 |
Last Split Date | Oct. 16, 2000 |
Risk Metrics
Estimates
Income Statement
Balance Sheet
Cash Flow Statement
Cash from Financing (TTM) | -4.963B |
Cash from Investing (TTM) | 2.887B |
Cash from Operations (TTM) | 2.29B |
Capital Expenditures (TTM) | Upgrade |
Common Size Statements
Net Income (% of Quarterly Revenues) | Upgrade |
Net Income (% of Annual Revenues) | Upgrade |
Earnings Quality
Accruals (Quarterly) | Upgrade |
Beneish M-Score (Annual) | Upgrade |
Profitability
Gross Profit Margin (Quarterly) | 70.09% |
Profit Margin (Quarterly) | 23.72% |
EBITDA Margin (TTM) | Upgrade |
Operating Margin (TTM) | Upgrade |
Management Effectiveness
Current Valuation
Liquidity and Solvency
Employee Count Metrics
Total Employees (Annual) | Upgrade |
Revenue Per Employee (Annual) | Upgrade |
Net Income Per Employee (Annual) | Upgrade |